Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2024 Results Conference Call September 26, 2024 4:30 PM ET
Company Participants
Robert Blum – IR, Lytham Partners
Josh Disbrow – Chief Executive Officer
Mark Oki – Chief Financial Officer
Conference Call Participants
Naz Rahman – Maxim Group
Operator
Greetings, welcome to the Aytu BioPharma’s Fiscal 2024 Q4 Earnings Call. At this time, all participants have been placed on a listen-only mode. [Operator Instructions] Please note this conference is being recorded.
I will now turn the conference over to your host, Robert Blum with Lytham Partners. You may begin.
Robert Blum
Alright. Thank you very much. Good afternoon, everyone and thank you for joining us, for as the operator indicted, Aytu BioPharma’s Fiscal 2024 full year and fourth quarter operational results and financial results conference call for the period ended June 30, 2024.
Joining us in today’s call is Aytu’s Chief Executive Officer, Josh Disbrow and the company’s Chief Financial Officer, Mark Oki. At the conclusion of today’s prepared remarks, we will open the call for a question-and-answer session.
I’d like to remind everyone that, today’s call is being recorded. A replay of today’s call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today, or by utilizing the link on the company’s website under Events and Presentations.
Finally, I’d also like to call your attention the customary safe harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations, and future potential operating results of Aytu BioPharma.
Although management believes these statements are reasonable based on estimates, assumptions, and projections as of today, these statements are not guarantees of future performance. Time-sensitive information may no longer be accurate at the time of any telephonic or webcast replay.
Read the full article here